HVA vs IA/DA or VA in the Treatment of ND HR-AML

NCT06810791 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

876

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Acute Myeloid Leukemia With High Risk

Interventions

DRUG: HVA
DRUG: VA
DRUG: Standard Chemotherapy

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]